Skip to main content

Corvus Pharmaceuticals, Inc. - Common Stock (NQ: CRVS )

4.990 -0.100 (-1.96%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist

Other Filings

Form DEFA14A
Source: SEC/Edgar
April 23, 2019
Form DEF 14A
Source: SEC/Edgar
April 23, 2019
Form 8-K
Source: SEC/Edgar
March 06, 2019
Form SC 13G
Source: SEC/Edgar
February 13, 2019
Form SC 13G/A
Source: SEC/Edgar
February 13, 2019
Form SC 13G/A
Source: SEC/Edgar
February 12, 2019
Form SC 13G/A
Source: SEC/Edgar
February 11, 2019
Form 8-K
Source: SEC/Edgar
February 05, 2019
Form SC 13D/A
Source: SEC/Edgar
January 30, 2019
Form 8-K
Source: SEC/Edgar
January 27, 2019
Form 8-K
Source: SEC/Edgar
January 09, 2019
Form 8-K
Source: SEC/Edgar
January 07, 2019
Form 8-K
Source: SEC/Edgar
December 13, 2018
Form 8-K
Source: SEC/Edgar
November 12, 2018
Form 8-K
Source: SEC/Edgar
October 31, 2018
Form 8-K
Source: SEC/Edgar
October 21, 2018
Form 8-K
Source: SEC/Edgar
October 02, 2018
Form 10-K/A
Source: SEC/Edgar
August 16, 2018
Form 8-K
Source: SEC/Edgar
August 01, 2018
Form 8-K
Source: SEC/Edgar
June 27, 2018
Form 8-K
Source: SEC/Edgar
June 21, 2018
Form 8-K
Source: SEC/Edgar
May 02, 2018
Form DEFA14A
Source: SEC/Edgar
April 26, 2018
Form DEF 14A
Source: SEC/Edgar
April 26, 2018
Form 8-K
Source: SEC/Edgar
April 25, 2018
Form 8-K
Source: SEC/Edgar
March 20, 2018
Form SC 13D
Source: SEC/Edgar
March 20, 2018
Form SC 13G
Source: SEC/Edgar
March 18, 2018
Form SC 13D/A
Source: SEC/Edgar
March 13, 2018
Form S-8
Source: SEC/Edgar
March 12, 2018
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.